The 2025 Simon-Kucher CDMO Growth Report paints a picture of a sector that’s optimistic but facing real operational and strategic friction. Demand is rising, pipelines are shifting toward more complex modalities, and capacity is tightening in ways that will reshape where CDMOs can win. Across my work with CDMOs and their pharma partners, I’m seeing many of the same tensions…